These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 210195)

  • 1. A smoking satiation procedure with reduced medical risk.
    Tori CD
    J Clin Psychol; 1978 Apr; 34(2):574-7. PubMed ID: 210195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring smoking withdrawal procedures to personality and motivational differences.
    Best JA
    J Consult Clin Psychol; 1975 Feb; 43(1):1-8. PubMed ID: 1114219
    [No Abstract]   [Full Text] [Related]  

  • 3. Smoking treatment strategies, expectancy outcomes, and credibility in attention-placebo control conditions.
    Hynd GW; Stratton TT; Severson HH
    J Clin Psychol; 1978 Jan; 34(1):182-6. PubMed ID: 346606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aversive cigarette smoking as a smoking cessation procedure.
    Dawley HH; sardenga PB
    J Clin Psychol; 1977 Jan; 33(1):234-9. PubMed ID: 833308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypnosis for Smoking Relapse Prevention: A Randomized Trial.
    Carmody TP; Duncan CL; Solkowitz SN; Huggins J; Simon JA
    Am J Clin Hypn; 2017 Oct; 60(2):159-171. PubMed ID: 28891777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project.
    Fortmann SP; Killen JD; Telch MJ; Newman B
    JAMA; 1988 Sep; 260(11):1575-80. PubMed ID: 3045351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aversive smoking for smoking cessation.
    Hajek P; Stead LF
    Cochrane Database Syst Rev; 2000; (2):CD000546. PubMed ID: 10796558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance by gender in a stop-smoking program combining hypnosis and aversion.
    Johnson DL; Karkut RT
    Psychol Rep; 1994 Oct; 75(2):851-7. PubMed ID: 7862796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response prevention in the treatment of cigarette smoking.
    Corty E; McFall RM
    Addict Behav; 1984; 9(4):405-8. PubMed ID: 6532149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of rapid smoking in a community service smoking withdrawal program.
    Pederson LL; Scrimgeour WG; Lefcoe NM
    Int J Addict; 1980 Jul; 15(5):615-29. PubMed ID: 7419297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic and sensorimotor components of satiation in cigarette smoking.
    Rose JE; Behm FM; Westman EC; Bates JE; Salley A
    Pharmacol Biochem Behav; 2003 Sep; 76(2):243-50. PubMed ID: 14592675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial.
    Ockene JK; Kristeller J; Goldberg R; Amick TL; Pekow PS; Hosmer D; Quirk M; Kalan K
    J Gen Intern Med; 1991; 6(1):1-8. PubMed ID: 1999742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of PROP Taste Phenotype, Taste Receptor Genotype, and Oral Nicotine Replacement Use.
    Ahijevych K; Tepper BJ; Graham MC; Holloman C; Matcham WA
    Nicotine Tob Res; 2015 Sep; 17(9):1149-55. PubMed ID: 25542917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on smoking quit rate of telling smokers their health risk appraisal in terms of health age: a randomized control trial.
    Paek YJ; Lee S; Kim YH; Lee KS; Yim HW; Kim MS; Kim CH; Jeung O
    Asian Pac J Cancer Prev; 2014; 15(12):4963-8. PubMed ID: 24998572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satiation and sensory deprivation combined in smoking therapy: some case studies and unexpected side-effects.
    Suedfeld P; Best JA
    Int J Addict; 1977 Apr; 12(2-3):337-59. PubMed ID: 873658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of abstinence from smoking among participants in a smoking cessation program in a health center in Japan].
    Suzuki J; Nakaide K; Nakamura Y; Kanetaka K; Nakai S; Harada H
    Nihon Koshu Eisei Zasshi; 2006 Mar; 53(3):187-95. PubMed ID: 16689273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral activation for smoking cessation and mood management following a cardiac event: results of a pilot randomized controlled trial.
    Busch AM; Tooley EM; Dunsiger S; Chattillion EA; Srour JF; Pagoto SL; Kahler CW; Borrelli B
    BMC Public Health; 2017 Apr; 17(1):323. PubMed ID: 28415979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.